CEPHEID Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (18)

Latest Posts

About This Stock More About This Stock
Biotechnology Bear Market: Trends To Watch For A 2016 Q4 Rally
Article By: Rod Raynovich
Wednesday, October 12, 2016 11:02 PM EST
IBB is at $270 midway between Brexit bottom of $242 and recent top of $300
In this article: ALNY, CPHD, IBB, ILMN, MDVN, CELG, XBI, XLV
Read
Rayno 2016 Life Science Portfolio Update
Article By: Rod Raynovich
Thursday, September 29, 2016 8:14 PM EST
Biotech stocks are near their intermediate highs but still down in 2016 : IBB at $295 down 12.78% and the XBI​ at $67.80 down 3.42% YTD.
In this article: ALR, BMY, TMO, RHHBY, CPHD, IBB, ILMN, AMGN, GILD, XBI, ABBV, BLUE, FMI
Read
Biotech ETFs Lead Q3 Rally: XBI Breaks Out
Article By: Rod Raynovich
Thursday, September 22, 2016 8:00 PM EST
The biotech sector is doing much better since BREXIT in late June despite a sell-off in late August. We are still trying to escape a bear market mentality because of the Q1 correction and concerns about drug prices.
In this article: AGN, JNJ, MDT, CPHD, ILMN, REGN, AMGN, BIIB, CELG, GILD, QGEN, XBI, XLV, Q, SRPT, BLUE, TSRO, IONS
Read
Deal Of The Day: Cepheid Sells Out To Danaher For $4B
Article By: Rod Raynovich
Tuesday, September 6, 2016 5:39 PM EST
Many stocks in the sector were movers today benefiting from the Cepheid deal.
In this article: DHR, CPHD Also: GHDX, ILMN, HOLX, PACB, EXAS, AXDX, FMI, NVTA
Read
J.P.Morgan Healthcare Conference #1: Investors Move Into Life Science Stocks-Bouncing Off The Bottom
Article By: Rod Raynovich
Tuesday, January 12, 2016 8:28 PM EST
We have a long way to recover in this bear market. The IBB​ touched near 52 week lows yesterday at $287 and is currently at $296 after a failed bounce then a recovery. We are down about 12% over five days.
In this article: ALR, JPM, NGS, TMO, RHHBY, CPHD, IBB, ILMN, ABAX, AFFX, QGEN
Read

Latest Tweets for $CPHD

No tweets yet!